Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study

Clinical trial NCT05972577 · COMPLETED

Trial details

NCT number: NCT05972577
Sponsor: Ohio State University Comprehensive Cancer Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Aplastic Anemia Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Hematopoietic and Lymphoid Cell Neoplasm Hodgkin Lymphoma Myelodysplastic Syndrome Myelofibrosis Myeloproliferative Neoplasm Non-Hodgkin Lymphoma Plasma Cell Myeloma

Start date: 2021-06-11
Primary completion: 2024-11-13
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.